61 related articles for article (PubMed ID: 2275311)
1. [Hepatitis B virus in patients with renal transplant. Report of 52 cases].
Duncan CR; Virginillo MB; Palmitano JB; Tani RD; Aguirre C
Acta Gastroenterol Latinoam; 1990; 20(2):75-80. PubMed ID: 2275311
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection.
Matos CA; Perez RM; Lemos LB; Medina-Pestana JO; Lanzoni VP; Alberto FL; Moreira ES; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):653-7. PubMed ID: 17625434
[TBL] [Abstract][Full Text] [Related]
3. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.
Berber I; Aydin C; Yigit B; Turkmen F; Titiz IM; Altaca G
Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070
[TBL] [Abstract][Full Text] [Related]
4. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
Sumethkul V; Ingsathit A; Jirasiritham S
Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
[TBL] [Abstract][Full Text] [Related]
5. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
Ramakrishna B; Mukhopadhya A; Kurian G
J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
Huang YW; Liu CJ; Lai MY; Lee PH; Tsai MK; Wang SS; Lai MK; Kao JH
Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306
[TBL] [Abstract][Full Text] [Related]
7. HBV DNA and other hepatitis B virus markers in sera from long-term hemodialysis and kidney transplant patients.
Theilmann L; Gmelin K; Rambausek M; Dreikorn K; Bommer J; Kommerell B; Pfaff E
Hepatogastroenterology; 1988 Aug; 35(4):147-50. PubMed ID: 3053386
[TBL] [Abstract][Full Text] [Related]
8. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
Chan TM; Fang GX; Tang CS; Cheng IK; Lai KN; Ho SK
Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336
[TBL] [Abstract][Full Text] [Related]
9. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
Fabrizio F; Bunnapradist S; Martin P
J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272
[TBL] [Abstract][Full Text] [Related]
10. Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease.
Günther S; Baginski S; Kissel H; Reinke P; Krüger DH; Will H; Meisel H
Hepatology; 1996 Oct; 24(4):751-8. PubMed ID: 8855172
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies.
Harnett JD; Zeldis JB; Parfrey PS; Kennedy M; Sircar R; Steinmann TI; Guttmann RD
Transplantation; 1987 Sep; 44(3):369-76. PubMed ID: 2820093
[TBL] [Abstract][Full Text] [Related]
12. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
Abdelmalek MF; Pasha TM; Zein NN; Persing DH; Wiesner RH; Douglas DD
Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824
[TBL] [Abstract][Full Text] [Related]
13. Changes in serological markers of hepatitis B virus after renal transplantation.
Urbini Dos Santos C; Sevá-Pereira T; Alves-Filho G; Lorena SL; Soares EC; Mazzali M
Transplant Proc; 2008 Apr; 40(3):749-51. PubMed ID: 18455006
[TBL] [Abstract][Full Text] [Related]
14. The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
Gwak GY; Huh W; Lee DH; Choi MS; Lee JH; Koh KC; Kim SJ; Joh JW; Oh HY
Transplant Proc; 2007 Dec; 39(10):3121-6. PubMed ID: 18089336
[TBL] [Abstract][Full Text] [Related]
15. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
[TBL] [Abstract][Full Text] [Related]
16. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
[TBL] [Abstract][Full Text] [Related]
17. HBV and HCV infection in kidney transplant recipients.
Frider B; Castaño G; Sookoian S; Livellara B; Kina M; Sabatiello R; Castiglione T; Iotti R; Vázquez MC
Acta Gastroenterol Latinoam; 1993; 23(2):75-81. PubMed ID: 8249531
[TBL] [Abstract][Full Text] [Related]
18. Renal transplant in hepatitis B and C positive patients--a ten years experience.
Rathod JR; Sirsat RA; Shah BV
J Assoc Physicians India; 2002 Jun; 50():766-70. PubMed ID: 12240839
[TBL] [Abstract][Full Text] [Related]
19. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
20. Histological, biochemical and clinical findings in hepatitis B carriers undergoing elective abdominal surgery.
Pramoolsinsap C; Kurathong S; Bunyaratvej S
Southeast Asian J Trop Med Public Health; 1988 Dec; 19(4):571-8. PubMed ID: 3238467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
